Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1645-1656
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1645
Table 1 Demographics and characteristics of patients, defects, and over-the-scope clips
CharacteristicsDetailsTotal patients (n = 58)
Age, median (range), yr77 (37-98)
Indications, n
Refractory bleeding18
Ulcer (peptic, Behçet's, anastomosis)12
Mallory-Weiss tear1
Diverticula2
Post-endoscopic resection3
Leaks28
Peptic ulcer3
Boerhaave1
Iatrogenic (ESD)16
Iatrogenic (ERCP)2
Iatrogenic (surgery)4
Iatrogenic (other)2
Fistula12
PEG6
Rectum-bladder1
Rectum-pelvis2
Gastric tube-trachea1
Gastric-pseudopancreatic cyst1
Colon-gallbladder1
Location, n
Esophagus3
Stomach28
Duodenum13
Small intestine2
Colon12
Maximum defect size (D) mm, n
D ≤ 1025
10 < D ≤ 209
20 < D24
Median (range), mm15 (3-50)
Duration since onset to OTSC placement, n
Immediate ≤ 1 d25
1 < Acute ≤ 7 d11
Chronic > 7 d22
Suction method into the applicator cap
Simple suction14
Twin Grasper (TG) assist42
Anchor assist2
The number of OTSC deployments, n
021
139
212
35
Table 2 Results of major outcomes
OutcomesTotal patients (n = 58)
Technical success rate, % (95%CI)89.7 (81.0-98.4)
Clinical success rate, % (95%CI)84.5 (74.3-94.7)
Complications, n (%)1 (1.8) in 56 cases used
The procedure time, median (range), min8 (1-36) in 52 successful cases
Table 3 Results of the technical and clinical success rates for each parameter
ParametersTotal patients (n = 58)
Technical success rateClinical success rate
Indications
Refractory bleeding88.9 (16/18)83.3 (15/18)
Leak89.3 (25/28)85.7 (24/28)
Fistula91.7 (11/12)83.3 (10/12)
Location
Upper GI tract86.4(38/44)81.8 (36/44)
Lower GI tract100 (14/14)92.9 (13/14)
Maximum defect size (D), mm
D ≤ 1096 (24/25)84 (21/25)
10 < D ≤ 2088.9 (8/9)88.9 (8/9)
20 < D83.3 (20/24)83.3 (20/24)
Duration since onset, % (n)
Immediate ≤ 1 d96 (24/25)96 (24/25)
1 < Acute ≤ 7 d90.9 (10/11)81.8 (9/11)
Chronic > 7 d81.8 (18/22)72.7 (16/22)
Suction method into the applicator cap
Simple suction (SS)100 (14/14)78.6 (11/14)
Twin Grasper (TG) Anchor assist88.1 (37/42) 50 (1/2)88.1 (37/42) 50 (1/2)
The number of OTSC deployments, n
192.3 (36/39)84.6 (33/39)
2100 (12/12)100 (12/12)
380 (4/5)80 (4/5)
Table 4 Outcomes of the simple suction and Twin Grasper methods n (%)
ParametersSS-method (n = 14)TG-method (n = 42)P value
Technical success rate14 (100)37 (88.1)0.1761
Clinical success rate11 (78.6)37 (88.1)0.3781
Procedure time, median (range), min5 (1-16)12 (3-36) in 37 successful cases0.00042
Complications0 (0)1 (2.4)0.5871
Table 5 Results of the technical and clinical success rates of the simple suction- and Twin Grasper-groups for each parameter
ParametersTechnical success rate
Clinical success rate
SS (n = 14)TG (n = 42)P value1SS (n = 14)TG (n = 42)P value1
Indication
Refractory bleeding100 (7/7)81.8 (9/11)0.231585.7 (6/7)81.8 (9/11)0.8288
Leak100 (2/2)92 (23/25)0.677650 (1/2)92 (23/25)0.0690
Fistula100 (5/5)83.3 (5/6)0.338480 (4/5)83.3 (5/6)0.8865
Location
Upper GI tract100 (8/8)85.3 (29/34)0.872575 (6/8)85.3 (29/34)0.8725
Lower GI tract100 (6/6)100 (8/8)83.3 (5/6)100 (8/8)0.2308
Maximum defect size (D), mm
D ≤ 10100 (14/14)100 (9/9)78.6 (11/14)100 (9/9)0.1364
10 < D ≤ 20-88.9 (8/9)--88.9 (8/9)-
20 < D-83.3 (20/24)--83.3 (20/24)-
Duration since onset, % (n)
Immediate ≤ 1 d100 (3/3)95.5 (21/22)0.6994100 (3/3)95.5 (21/22)0.6994
1 < Acute ≤ 7 d100 (3/3)87.5 (7/8)0.124766.7 (2/3)87.5 (7/8)0.1247
Chronic > 7 d100 (8/8)75 (9/12)0.125075 (6/8)75 (9/12)1.0000
Table 6 Comparison of the clinical success rates for the combined parameters in each indication
Clinical success rate
IndicationsRefractory bleeding (n = 18)Leak (n = 27)Fistula (n = 11)

Combined parametersSS (n = 7)TG (n = 11)SS (n = 2)TG (n = 25)SS (n = 5)TG (n = 6)
D ≤ 10, Immediate100%100%-100%--
D ≤ 10, Acute100%-50%100%--
D ≤ 10, Chronic66.7%100%--80%100%
10 < D ≤ 20, Immediate-100%-66.7%--
10 < D ≤ 20, Acute-100%-100%--
10 < D ≤ 20, Chronic-100%---100%
D > 20, Immediate-100%-100%--
D > 20, Acute---75%--
D > 20, Chronic-33.3%---50%
Table 7 Details of over-the-scope clips clinical failure cases (n = 8)
IndicationMax. defect size, mmCause, comorbidityLocationPrior therapyDuration since onsetTechnical successTechnical or clinical failure factorAdditional therapyClinical outcome
Refractory bleeding8Ileal ulcer bleeding due to steroid treatment for myelodysplastic syndromeTerminal ileumEI (hemoclips and coagulation)ChronicYesSuspicion of angiogenesis due to steroid in particular circumstancesElective surgerySurvival
Refractory bleeding20Peptic ulcer, Refractory neurogenic diseaseStomach (body)EI (coagulation)ChronicNoFibrotic tissueRetry of EISurvival
Refractory bleeding50Peptic ulcer, Advanced gallbladder carcinomaStomach (body)EI (coagulation)ChronicNoFibrotic tissueRetry of EISurvival
Leak7Anastomotic leakage after surgery for gastric cancerEsophageal gastric junctionNoneAcuteYesLeakage by mucosal suture (suspected)Elective surgerySurvival
Leak21Perforation during ERCPDuodenal 2nd portionNoneImmediateNoInability of platformEmergency surgerySurvival
Leak50Delayed perforation after ESDStomach (prepyrolus)NoneAcuteNoLocation with narrow lumenElective surgerySurvival
Fistula8Interventional EUSGastric (prepyrolus)- pseudopancreatic cystNoneChronicYesLeakage by mucosal suture (suspected)Elective surgerySurvival
Fistula22Radiation for esophageal carcinomaGastric tube-tracheaBronchial embolizationChronicNoFibrotic tissueElective surgerySurvival
Table 8 Current clinical outcomes of over-the-scope clips for each indication
Ref.YearCountryPatients (n)Overall clinical success rate, (success/ total)
Mean defect size (mm)Described data of suction methodComplications, n (%)
Refractory bleedingLeaks and/or perforationsFistulaOthersTotal
Albert et al[20]2011Germany1957.1 (4/7)87.5 (7/8)25 (1/4)-63.2UnknownUnknown0
Surace et al[21]2011France, Monaco19--74 (14/19)-73.7UnknownUnknown1 (5)
Kirschniak et al[22]2011Germany5092.6 (25/27)100 (11/11)37.5 (3/8)100 (4/4)866Unknown0
Baron et al[19]2012United States45100 (7/7)62.5 (5/8)67.9 (19/28)50 (1/2)71UnknownTG: 8 cases AC: 17 cases2 (4.4)
Manta et al[23]2013Italy3090 (27/30)---90UnknownUnknown0
Haito-Chavez et al[15]2014International2188-Leaks 73.3 (22/30), 21 Perforations 90 (36/40), 8142.9 (39/91), 171-60.2Leaks: 8 Perforations: 7 Fistula: 5Use of TG and/or AC, 50% (70/140 cases)30
Law et al[24]2014United States47--53 (25/47)-53UnknownUnknown0
Sulz et al[25]2014Switzerland21100 (1/1)66.7 (4/6)63.6 (7/11)100 (3/3)71.48SS:4 100% (10/10) TG:100% (1/1) AC: 87.5% (7/8) TG + AC: 0% (0/1)0
Mercky et al[26]2015France, Monaco30--53 (16/30)-537.2SS: 17 procedures TG: 9 procedures AC: 5 procedures4 (13.3)
Our study2016Japan5883.3 (15/18)85.7 (24/28)83.3 (10/12)-84.519.6CSR SS4: 78.6% (11/14) TG: 88.1% (37/42) AC: 50% (1/2)1 (1.8)
Total50787.8 (79/90)83.2 (109/131)53.0 (133/251)88.9 (8/9)68.4 (329/481)8/481 (1.66)